CVS raises outlook amid solid returns at health care benefits segment

Published 31/07/2025, 11:42

Investing.com - CVS has once again raised its full-year profit forecast, as the conglomerate said it was boosted by strength at its health care benefits and pharmacy and consumer wellness segments.

Under CEO David Joyner, who took over at the helm of the company in October, CVS has been pushing to cut costs and has reshuffled its executive leadership team as it looks to turn around its fortunes following one of the most challenging periods in its six-decade history.

In a statement, CVS said it has seen "significant and durable recovery"at its Aetna unit, as well as "growth and momentum" at its pharmacy division.

Second-quarter net revenue grew by 8.4% versus a year ago to $98.92 billion, compared to analysts’ estimates of $94.61 billion, fueled by better-than-anticipated results at its health care benefits and health services businesses.

Adjusted earnings per share operating income edged up by 1.7% to $3.81 billion, while earnings per share came in at $1.81 -- both topping Wall Street projections.

Following the returns, CVS said it expects adjusted per-share income to be between $6.30 to $6.40, up from a prior guidance of $6 to $6.20. Cash flow from operations is anticipated to be at least $7.5 billion, versus $7 billion previously.

Shares of CVS ripped higher by more than 8% in premarket U.S. trading on Thursday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.